AnaptysBio authorizes $100 million stock buyback plan
AnaptysBio Inc. (NASDAQ: ANAB) announced its board of directors authorized a $100 million stock repurchase program and provided updates on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
